ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation headquartered in Newark, New York, filed this Current Report on Form 8-K on April 1, 2025. The filing serves to announce the financial results for the fourth quarter and full year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No material changes or comparative financial data are disclosed within the text of this filing. The document solely references the issuance of a press release containing the results.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information, if any, is located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 1, 2025) for specific Q4 and full-year 2024 financial figures.
- Verify the trading symbol ULBI on the NASDAQ Stock Market for current stock performance.
- Confirm the full text of the press release to assess any guidance or material events not summarized in the 8-K cover page.